AspirinAsthmaAnti-Asthmatic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalAsthma, Exercise-InducedAdministration, InhalationPeak Expiratory Flow RateAsthma, OccupationalForced Expiratory VolumeBronchial HyperreactivityBronchodilator AgentsRespiratory SoundsAllergensAdrenal Cortex HormonesTiclopidineThromboxane B2HypersensitivityAsthma, Aspirin-InducedCyclooxygenase InhibitorsPlatelet AggregationHypersensitivity, ImmediateRhinitisDrug Therapy, CombinationSalicylatesRespiratory Function TestsAlbuterolMethacholine ChloridePlatelet Function TestsRisk FactorsRhinitis, Allergic, PerennialDouble-Blind MethodSpirometryEosinophilsBronchiBudesonideSeverity of Illness IndexBeclomethasoneLeukotriene AntagonistsPrevalenceSkin TestsNebulizers and VaporizersLungTreatment OutcomeQuestionnairesBlood PlateletsSodium SalicylateStatus AsthmaticusBronchoconstrictor AgentsAirway RemodelingProspective StudiesDose-Response Relationship, DrugBronchoconstrictionBronchitisFibrinolytic AgentsAdrenergic beta-AgonistsRespiratory HypersensitivityAnti-Inflammatory AgentsOvalbuminTime FactorsHemorrhagePyroglyphidaeAnticoagulantsWarfarinTablets, Enteric-CoatedCase-Control StudiesCyclooxygenase 1Cohort StudiesFollow-Up StudiesPulmonary MedicineVital CapacityGlucocorticoidsProstaglandin-Endoperoxide SynthasesPlatelet ActivationThromboxanesBleeding TimeGastrointestinal HemorrhageSputumBronchoalveolar Lavage FluidCross-Sectional StudiesCoughExhalationIbuprofenAcetaminophenThromboxane A2Airway ObstructionDrug ResistanceAir Pollution, IndoorOccupational DiseasesEosinophiliaDrug HypersensitivityMitesOdds RatioEnvironmental ExposureLipoxinsThrombosisCromolyn SodiumAir PollutantsCyclooxygenase 2 InhibitorsPractice Guidelines as Topic